重症心身障害児(者)における急性膵炎発症の危険因子の検討 by Tamasaki, Akiko
1 
 
Risk factors for acute pancreatitis in patients with severe motor and intellectual 
disabilities 
 
*Akiko Tamasaki, Yoko Nishimura, Noriko Kondo, Kentaro Shirai, Yoshihiro 
Maegaki, Kousaku Ohno 
 
Division of Child Neurology, Institute of Neurological Science, Faculty of Medicine, 
Tottori University, Yonago, Japan 
 
 
 
*Corresponding author:  
Akiko TAMASAKI, Division of Child Neurology, Institute of Neurological Science, 
Faculty of Medicine, Tottori University 
36-1 Nishi-cho, Yonago, 683-8504, Japan 
Tel: +81 859 38 6777 
Fax: +81 859 38 6779 
E-mail address: holbergs@nifty.com 
 
2 
 
Abstract 
 Aim: Acute pancreatitis in patients with severe motor and intellectual disabilities 
(SMID) is a rare but life-threatening condition. Possible causes of acute pancreatitis in 
these patients including valproic acid therapy, hypothermia and nasoduodenal tube 
feeding, have not yet been investigated in detail. This study aimed to investigate the 
risk factors for acute pancreatitis in patients with SMID. Methods: We reviewed 5 
SMID patients with acute pancreatitis and 15 SMID patients without acute pancreatitis. 
Age; serum levels of total cholesterol, triglyceride, total protein, and albumin; height; 
body weight; body surface area; body mass index; daily calorie intake; daily calorie 
intake per unit of body mass surface area; daily calorie intake per kilogram body 
weight; and valproic acid usage were examined. Results: Statistically significant 
difference was observed in serum albumin levels between (P = 0.026) the two groups. 
Conclusion: The mechanism of acute pancreatitis in these patients was considered as 
pancreatic morphological change, acinar damage, and elevated serum trypsinogen 
levels caused by malnutirition. It is likely that acute pancreatitis in patients with SMID 
occur by the similar mechanism with anorexia nervosa and malnourished patients. To 
prevent acute pancreatitis in these patients, it is important to maintain adequate 
nutritional status. 
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1. Introduction 
 Acute pancreatitis in patients with severe motor and intellectual disabilities (SMID) 
may be life-threatening. Moreover, it can be difficult to diagnose because signs and 
symptoms are usually nonspecific: fever, abdominal distention, gastric bleeding, 
bilious vomiting, and diarrhea. A delay in diagnosis and treatment can have very 
serious, even fatal. Various risk factors for acute pancreatitis occurring in patients with 
SMID have been reported: valproic acid (VPA) therapy,1 scoliosis, nasoduodenal tube 
feeding, and hypothermia.2 However the mechanisms by which these factors work 
have not been examined in details. This study examined the risk factors of acute 
pancreatitis in patients with SMID to aid in the prevention of this critical condition. 
 
2. Patients and methods 
SMID patients with acute pancreatitis (n = 5: 2 males, 3 females) and without acute 
pancreatitis (n = 15: 8 males, 7 females) were identified retrospectively from a 
database containing information about all children who visited our division from 2007 
to 2012. All patients were bed-ridden and diagnosed with SMID patinets. Table 1 
displays the clinical profiles of patients with SMID in acute pancreatitis group 
(pancreatitis group). Underlying diseases in SMID patients without pancreatitis 
(control group) included hypoxic-ischemic encephalopathy (n = 2), severe neonatal 
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asphyxia (n = 4), microcephaly and brain anomaly (n = 2), bacterial 
meningoencephalitis (n = 1),  sepsis associated encephalopathy (n = 1), cerebral 
palsy (n = 1), Sotos syndrome (n = 1), congenital central hypoventilation syndrome (n 
= 1), Niemann-Pick disease type C (n = 1), and adrenoleukodystrophy (n = 1). In the 
pancreatitis group, acute pancreatitis recurred four times in one patient and eight times 
in another patient; in these two patients abdominal echo and magnetic resonance 
cholangiopancreatography were performed. No anomalous arrangement of 
pancreaticobiliary ducts or biliary duct dilatation were recognized. Antibody levels to 
cytomegalovirus, varicella-zoster virus, coxsackie virus, Epstein-Barr virus, and 
hepatitis A, B, and C virus, were examined in one of these patients, but no elevated 
levels were detected.  
In two patients with SMID in pancreatitis group, the serum VPA levels at the onset of 
acute pancreatitis was 116.4μg/ml and 63.1μg/ml, the duration of VPA treatment 
was 7 years and 10 months, 2 years and 6 months, respectively. In two SMID patients 
medicated by VPA in control group, the serum concentration of VPA was 75.6μg/ml 
and 23.5μg/ml, the duration of VPA treatment was 3 years and 6 months, 4 years and 
3months, respectively. 
Diagnosis of acute pancreatitis was made on the basis of laboratory findings 
(elevation of serum pancreatic amylase and lipase) and abdominal computed 
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tomography (CT) findings (pancreatic enlargement and infiltration of surrounding fat). 
No gallstone revealed on abdominal CT in any patient. 
Patients were compared in terms of following parameters: age; sex; respiratory care; 
feeding methods; valproic acid therapy; serum levels of total cholesterol, triglyceride, 
total protein and albumin; height; body weight; body surface area (BSA); body mass 
index [BMI, calculated by using the following equation: weight (kg)/height (m)2]; 
daily calorie intake; daily calorie intake per unit of BSA; daily calorie intake per 
kilogram of body weight. In the pancreatitis group, the serum levels of total 
cholesterol, triglyceride were selected at the onset of acute pancreatitis and the serum 
levels of total protein, albumin were selected that had been collected when patients 
were in good general condition one or two months before the onset of acute 
pancreatitis. For the two patients with recurrent disease in the pancreatitis group, 
quantitative data were selected that had been collected before the first episode of acute 
pancreatitis. 
Statistical analysis 
 Quantitative data were retrospectively examined using the Mann-Whitney U test. 
The chi-square test was applied for comparison of results by sex, respiratory care, 
feeding methods, VPA therapy. Quantitative and qualitative data except for VPA 
therapy was analyzed after excluding the SMID patients medicated by VPA. The 
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significance level was determined as P < 0.05. 
 
3. Results 
Significant difference in serum albumin level was observed (P < 0.05) between 
patients in the pancreatitis and control groups. No significant difference in age, sex, 
respiratory care, feeding method, VPA therapy, height, body weight, BSA, BMI, daily 
calorie intake, daily calorie intake per unit of BSA, daily calorie intake per kilogram 
of body weight, serum total protein, total cholesterol and triglyceride level were 
evident between groups (Tables 2 and 3).  
 
4. Discussion 
 Acute pancreatitis is triggered by pancreatic autodigestion, which is followed by 
activation of pancreatic enzymes. Some etiologies of acute pancreatitis were known, 
including viral infection, multisystem disease, hyperlipidemia, drugs, trauma, 
autoimmune disease, congenital anomalies of the pancreaticobiliary system, 
malnutrition.3 VPA is known as one of the drug caused with acute pancreatitis. In this 
study, the risk of VPA therapy was untried because the numbers medicated by VPA 
were poor. The past articles show that dose, duration of treatment, serum VPA levels 
are no concern of acute pancreatitis.1, 4 Additionally there is no evidence that VPA is 
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an independent risk factor of acute pancreatitis.5  
 Recurrent acute pancreatitis in anorexia and bulimia6 and acute and chronic 
pancreatitis in patients with protein energy malnutrition were previously reported.7 
Cleghorn et al. reported that acinar cell damage and ductal obstruction were reflected 
by higher levels of serum trypsinogen in moderately and severely malnourished 
patients than in normally nourished patients.8 Moreover, marked acinar cell atrophy 
has been demonstrated in malnourished animals,9 and increased zymogen granule 
release has been found in malnourished patients.10 A protein-deficient diet causes a 
decrease in size and number of zymogen granules in acinar cells because zymogen 
granules are produced from protein; this results in acinar cell destruction.11, 12 In 
addition, protein energy malnutrition (marasmus, kwashiorkor) may lead to oxidative 
damage to the pancreas in a system with poor antioxidant reserves and inflammatory 
damage to the pancreas by elevation of the cytokines interleukin-1, interleukin-6, and 
tumor necrosis factor-α.7 
In this study, serum albumin levels in SMID patients with acute pancreatitis were 
significantly lower than those in SMID patients without acute pancreatitis. No protein 
extravasation or urinary protein excretion were evident, probably because these 
laboratory data were collected at a time when the patients were in good general 
condition. The results of urine protein tests in the patients included in this study were 
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negative (data not shown). Thus, in this study data for serum albumin levels were 
considered as a reflection of patients’ nutritional status. However, a more detailed 
evaluation of nutritional status is required, including examination of rapid turnover 
protein; prealbumin, transferrin, and retinol binding protein for conclusive information 
on nutritional status in patients with SMID. 
Protein breakdown in malnourished patients reduces the body’s supply of amino 
acids and results in decreased synthesis of plasma proteins.13 Moreover, in patients on 
long-term bed rest, muscle wasting is caused by protein breakdown as well. In 
addition, recurrent infection increases the body’s protein consumption. This 
inadequate protein turnover may result in hypoalbuminemia in patients with SMID 
who are malnourished, bed-ridden, and subject to recurrent infection.  
Causes of acute pancreatitis in patients with SMID may be related to pathological 
changes in the pancreas occurring as a result of malnutrition similar to those observed 
in patients with anorexia nervosa and protein energy malnutrition. Fortunately, 
pancreatic malfunction due to malnutrition is reversible.11 Adequate nutritional control 
and minimizing the opportunity of infections may improve pancreatic function and 
prevent development of acute pancreatitis. 
In conclusion, the results of this study indicate that hypoalbuminemia are risk factors 
for acute pancreatitis in patients with SMID. Adequate management of nutritional 
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status in patients with SMID is important to prevent development of pancreatitis. 
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Table 1 Clinical profiles of SMID with acute pancreatitis 
Patient Age Sex Underlying disease Respiratory care  Feeding methods VPA therapy 
1 4y M hypoxic-ischemic 
encephalopathy 
oral suction nasoduodenal tube + 
2 4y F sepsis-associated 
encephalopathy 
tracheostomy, ventilator nasogastric tube - 
3 17y F severe neonatal asphyxia oral suction nasoduodenal tube - 
4 9y M spinocerebellar degeneration tracheostomy gastrostomy + 
5 24y M Millar-Dieker syndrome not required oral feeding - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Comparison of clinical profiles between patients in the pancreatitis and control groups 
 pancreatitis group control group P value 
age (years)* 17 (4-29) 7 (4-28) 0.497 
sex (male:female)* 0:3 8:5 0.054 
respiratory medical care    
tracheostomy* 0/3 (0%)  1/13 (7.7%) 0.617 
tracheostomy and ventilation*  1/3 (33%) 6/13 (46.1%) 0.304 
NPPV* 0/3 (0%) 2/13 (15.4%) 0.466 
only oral suction*  2/3 (66%)  2/13 (15.4%) 0.064 
no respiratory medical care*  0/3 (0%)  2/13 (15.4%) 0.466 
feeding method    
oral feeding* 1/3 (33%) 1/13 (7.7%) 0.231 
nasogastric tube* 1/3 (33%) 5/13 (38.5%) 0.227 
nasoduodenal tube* 1/3 (33%) 1/13 (7.7%) 0.509 
gastrostomy* 0/3 (0%) 6/13 (46.2%) 0.093 
valproic acid therapy 2/5 (40%) 2/15 (13.3%) 0.196 
Values are expressed as median (percentage). Age ranges (years) are also provided. 
NPPV: non-invasive positive pressure ventilation 
*The parameters were compared after excluding patients medicated by VPA. 
 
 
 
 
Table 3 Demographic and laboratory data in the pancreatitis and control groups 
 AP 
Median (range) 
Control 
Median (range) 
P  
Height (cm) 111.4 (105-141) 111.0 (85-161.5) 0.697 
BW (kg) 24.6 (17.2-33) 16.0 (7.8-33.4) 0.201 
BSA (m2) 0.968(0.703-1.013) 0.710 (0.431-1.273) 0.542 
BMI 15.6(12.3-26.5) 13.3 (9.5-20.9) 0.250 
Daily calorie intake (kJ) 2512 (1172-4353) 1674 (1256-5023) 0.735 
Daily calorie intake per BSA (kJ/m2) 2594(1667-4298) 3264 (1769-5515) 0.741 
Daily calorie intake per BW (kJ/kg) 76.2 (68.2-177.1) 131.0 (62.8-270.8) 0.276 
T-Chol (mg/dl) 169 (122-240) 148 (98-196) 0.459 
TG (mg/dl) 77 (23-425) 94 (30-300) 0.503 
TP (g/dl) 5.2 (4.5-7.2) 7.2 (6.1-8.5) 0.079 
Alb (g/dl) 2.4 (2.2-3.2) 4.2 (2.6-4.9) 0.026* 
Parameters compared after excluding patients on VPA. 
BW: body weight, BSA: body surface area, BMI: body mass index, T-Chol: total cholesterol,  
TG: triglyceride, TP: total protein, Alb: Albumin 
 
